Revolutionizing Healthcare: Pyrogen Testing Market Size Projected to Reach USD 3.3 billion by 2032 at a 8.2% CAGR

July 13, 2024 09:33 PM AEST | By EIN Presswire
 Revolutionizing Healthcare: Pyrogen Testing Market Size Projected to Reach USD 3.3 billion by 2032 at a 8.2% CAGR
Image source: EIN Presswire

Increase in prevalence of chronic diseases, growing initiatives for minimizing pyrogen contamination,& rise in R&D activities drive the growth of the market

PORTLAND, OREGON, UNITED STATES, July 13, 2024 /EINPresswire.com/ -- Allied Market Research published a report, titled, “Pyrogen Testing Market by Product and Service (Reagents & Kits, Instruments, and Services), Test Type (LAL Test, Rabbit Pyrogen Test, and Others), and End User, (Pharmaceutical & Biotechnology Companies, Medical Device Companies, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global pyrogen testing industry generated $1.5 billion in 2022, and is anticipated to generate $3.3 billion by 2032, witnessing a CAGR of 8.2% from 2023 to 2032.

𝐖𝐡𝐚𝐭 𝐀𝐫𝐞 𝐭𝐡𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐟𝐨𝐫 𝐏𝐲𝐫𝐨𝐠𝐞𝐧 𝐓𝐞𝐬𝐭𝐢𝐧𝐠?

Rise in prevalence of chronic diseases, growing initiatives for minimizing pyrogen contamination, and rise in R&D activities are the factors that drive the growth of the global pyrogen testing market. However, the limited standardization for pyrogen testing restricts market growth. Moreover, the high growth potential in emerging countries and rise in technological advancements in pyrogen testing presents new opportunities in the coming years.

𝐓𝐨𝐩 𝐏𝐲𝐫𝐨𝐠𝐞𝐧 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

• Merck KGaA
• Lonza Group
• Thermo Fisher Scientific Inc.
• FUJIFILM Holdings Corporation
• GenScript
• SEIKAGAKU CORPORATION
• Charles River Laboratories
• STERIS
• WuXi AppTec
• Eurofins Scientific

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/807

The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

𝐏𝐲𝐫𝐨𝐠𝐞𝐧 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: -

By product and service, the reagents and kits segment held the largest market share in 2022, accounting for nearly half of the global pyrogen testing market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to high adoption of regents & kits as they are serving as critical tools in detecting and quantifying pyrogens in pharmaceutical and biotechnology products.

By test type, the LAL test segment held the largest market share in 2022, accounting for more than half of the global pyrogen testing market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to technological advancements in LAL testing methodologies, including the development of kinetic turbidimetric and chromogenic assays, have enhanced the efficiency and accuracy of pyrogen detection.

By end user, the pharmaceutical and biotechnology companies segment accounted for the largest share in 2022, contributing to more than half of the global pyrogen testing market revenue, and is projected to maintain its lead position during the forecast period. This is attributed to the growth of the biopharmaceutical sector, which includes the development of complex drugs such as monoclonal antibodies, vaccines, and cell therapies led to rise in demand for advanced and precise pyrogen testing methodologies.

By region, North America held the largest market share in terms of revenue in 2022, accounting for more than two-fifths of the global pyrogen testing market revenue and is likely to dominate the market during the forecast period. This is attributed to its well-developed healthcare infrastructure, technological advancements in testing methodologies, pharmaceutical innovation and research and development activities have led to an increased demand for pyrogen testing.

However, the Asia-Pacific region is expected to witness the fastest CAGR of 9.4% from 2023 to 2032. This is attributed to expanding pharmaceutical and biotechnology sectors, the rise of contract manufacturing & research activities, and increased healthcare investments.

Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/807

𝐎𝐮𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐘𝐨𝐮 𝐀𝐧𝐬𝐰𝐞𝐫 𝐭𝐨 𝐁𝐞𝐥𝐨𝐰 𝐌𝐞𝐧𝐭𝐢𝐨𝐧𝐞𝐝 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧 𝐎𝐮𝐭𝐥𝐨𝐨𝐤

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐃𝐞𝐭𝐚𝐢𝐥𝐬:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
[email protected]

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.